Wikidata

(Q85055261)

English

Predominant expression of CCL2 at the tumor site of prostate cancer patients directs a selective loss of immunological tolerance to CCL2 that could be amplified in a beneficial manner

scientific article published on 07 December 2009

In more languages

Statements

title
Predominant expression of CCL2 at the tumor site of prostate cancer patients directs a selective loss of immunological tolerance to CCL2 that could be amplified in a beneficial manner (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19995900
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995900%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q85055261&oldid=2045334092"